CLINICAL_TRIALS
trial_result
· 2024-02-23
Clinical Trial Update: A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 clinical trial update for GZR18 injection in Chinese patients with Type 2 Diabetes Mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN